Litigation Details for Total Control Sports v. Precision Impact (N.D. Ill. 2017)
✉ Email this page to a colleague
Total Control Sports v. Precision Impact (N.D. Ill. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-12-26 |
| Court | District Court, N.D. Illinois | Date Terminated | 2020-03-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary M Rowland |
| Jury Demand | Both | Referred To | |
| Patents | 9,186,564 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Total Control Sports v. Precision Impact
The biologic drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Total Control Sports v. Precision Impact (N.D. Ill. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-12-01 | 70 | Memorandum Opinion and Order | U.S. Patent No. 8,702,542 (“the ‘542 patent”) and U.S. Patent No. 9,186,564 (“the ’564 patent”). Defendant…training a hitter using a weighted ball. U.S. Patent No. 9,186,564, Abstract. Depending on whether the ball…weight the ball does not travel as far. U.S. Patent No. 9,186,564, col. 5, lines 13-21. TCS maintains that…Like the ‘542 patent, the ‘564 patent went through multiple rounds of rejection by the patent office. See… [25], ¶¶2, 9. TCS owns both the ‘542 patent and the ‘564 patent, which are directed towards a weighted | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
